Studies have shown that the TERT promoter mutation is highly correlated with the prognosis of transitional cell carcinoma and confirmed that the −124 C > T mutation (corresponding to C228T) is associated with high expression of TERT and telomerase activity (36). This evidence concerns the gene TERT and transitional cell carcinoma.